Skip to main content

New publication on pseudotumoral lesions in MS co-authored by Prof. Jelena Drulovic

ParadigMS Foundation

By ParadigMS Foundation

January 30, 2025

Prof. Jelena Drulovic, ParadigMS Foundation Board Member, has co-authored the article Etiology and Characteristics of Pseudotumoral Lesions and Tumefactive Demyelination in Multiple Sclerosis, published in Elsevier in November 2024.

We are pleased to invite you to explore this publication, which provides valuable insights into the complexities of pseudotumoral MS lesions and their clinical implications.

The article titled “Etiology and Characteristics of Pseudotumoral Lesions and Tumefactive Demyelination in Multiple Sclerosis” delves into the complex nature of tumefactive demyelinating lesions (TDLs) in MS. These lesions, often resembling tumors due to their size and appearance, present significant diagnostic challenges. The study examines the underlying causes, clinical presentations, and distinguishing features of TDLs, aiming to enhance understanding and improve differentiation from other neurological conditions. By shedding light on these atypical manifestations, the research contributes valuable insights into the diagnosis and management of MS.


Authors: Olivera Tamas a b, Marija Kovacevic a, Nikola Veselinovic a b, Maja Budimkic a b, Vanja Jovicevic b, Nikola Momcilovic b, Jelena Drulovic a b, Sarlota Mesaros a b.

a. Faculty of Medicine, University of Belgrade, Serbia b. Neurology Clinic, University Clinical Center of Serbia, Serbia

Cerebral pseudotumoral lesions (CPTL) (>2cm) on magnetic resonance imaging (MRI) may pose a clinical challenge. A majority will occur in the context of multiple sclerosis (MS) – also referred to as tumefactive demyelinating lesions (TDL). The aim of this study was to define and analyse clinical, MRI, and paraclinical data for MS and non-MS patients.

This prospective study included adult patients with CPTL on brain MRI referred to the Neurology Clinic, Belgrade as a tertiary University Center (2019–2023) for clinical workup and treatment. Demographic, clinical, MRI, and paraclinical data were reviewed.

This study included 75 patients, of which 58.7 % had MS. Fourteen patients had previously been diagnosed with MS, while 30 (68.2 %) received the diagnosis of MS in the later course. The concordance of initial and final diagnoses was 52 %. Relapsing disease (p < 0.001) and brainstem presentation (p = 0.039) were significantly more common in MS patients. Headache (p = 0.008) and lethal outcome (p = 0.014) were significantly more common in the non-MS group. Lesions were ring-like more frequently in the MS group (p < 0.001), while patients in the non-MS group frequently displayed infiltrative (p = 0.001) and nonspecific lesions (p = 0.002). The presence of headache and megacystic morphology was associated with the presence of pathology other than MS while the relapsing disease was in favor of MS.

Multiple sclerosis was the most common cause of CPTL. Headache, relapsing course of disease, and megacystic morphology may help discern MS from non-MS pathology. These findings should be challenged in future studies examining larger cohorts.

The Article can be found on Elsevier website.


FAQs

Is ParadigMS for free?

Yes, a ParadigMS subscription is free for healthcare practitioniers. 

Do subscriptions auto-renew?
Your subscription will automatically renew on yearly basis. If you cancel your plan, it will not renew at the end of your subscription cycle. 
I am a representative from industry, can I subscribe?

Free subscriptions to ParadigMS are reserved for healthcare practitioners. If you are a representative of the industry please contact us on learning@paradigms.foundation and we would advise you how to get the access to the material. 

What happens if I subscribe as a HCP if I am not?
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, we will cancel your subscription immediately. 
I am a patient, can I subscribe?

ParadigMS is designed specifically for healthcare practitioners, with content and language tailored to their professional needs. While patients cannot subscribe directly, we encourage you to consult your healthcare provider for relevant insights and updates that may benefit you.

Why should I subscribe to ParadigMS's e-platform?

Subscribing to ParadigMS’s e-platform gives you access to up-to-date information and valuable learning materials on multiple sclerosis and NMO, along with expert insights and the latest innovations in the field. It’s an essential resource for staying informed and enhancing your knowledge in MS care.

How can I cancel my subscription?
You can cancel your subscription in your account settings. 
Can I financially support ParadigMS?

Yes, you can financially support ParadigMS! We welcome donations to help us continue our mission of advancing multiple sclerosis education and research. Your contribution directly supports the creation of educational resources, expert discussions, and innovative projects in MS care. Visit our donation page to learn more about how you can make a difference: ParadigMS Donate.